- PAM (positive allosteric modulator)
- Иммунология: позитивный аллостерический модулятор
Универсальный англо-русский словарь. Академик.ру. 2011.
PAM (positive allosteric modulator)
Смотреть что такое "PAM (positive allosteric modulator)" в других словарях:
Negative allosteric modulator — A negative allosteric modulator (NAM) is a drug which decreases the activity of a receptor indirectly via disactivation of an allosteric site on the protein. NAMs are similar to inverse agonists in that they conteract overall receptor activation … Wikipedia
PAM — or PAM may refer to: Contents 1 Companies 2 Organisations 3 Military … Wikipedia
Metabotropic glutamate receptor 2 — Glutamate receptor, metabotropic 2 Identifiers Symbols GRM2; GLUR2; GPRC1B; MGLUR2; mGlu2 External IDs … Wikipedia
Nicotinic agonist — A nicotinic agonist is a drug which enhances the action at the nicotinic acetylcholine receptor (nAChR). Examples include: nicotine (by definition the nicotinic acetylcholine receptor is named for its affinity for nicotine) acetylcholine, the… … Wikipedia
NMDA receptor antagonist — Ketamine, one of the most common NMDA receptor antagonists. NMDA receptor antagonists are a class of anesthetics that work to antagonize, or inhibit the action of, the N methyl d aspartate receptor (NMDAR). They are used as anesthesia for animals … Wikipedia
Receptor antagonist — This article is about the biochemistry term. For other uses, see Antagonist (disambiguation). Antagonists will block the binding of an agonist at a receptor molecule, inhibiting the signal produced by a receptor agonist coupling. A receptor… … Wikipedia
Reuptake inhibitor — Escitalopram, a selective serotonin reuptake inhibitor (SSRI) used as an antidepressant. A reuptake inhibitor (RI), also known as a transporter blocker, is a drug that inhibits the plasmalemmal transporter mediated reuptake of a neurotransmitter… … Wikipedia
Cholinergic — The N,N,N trimethylethanolammonium cation, with an undefined counteranion, X− … Wikipedia
Cannabinoid receptor antagonist — The discovery of the endogenous cannabinoid system led to the development of CB1 receptor antagonists. The first cannabinoid receptor antagonist, rimonabant, was described in 1994. Rimonabant blocks the CB1 receptor selectively and it has been… … Wikipedia
Monoamine oxidase inhibitor — MAOI redirects here. For the Easter Island statues, see Moai. Monoamine oxidase Monoamine oxidase inhibitors (MAOIs) are a class of antidepressant drugs prescribed for the treatment of depression. They are particularly effective in treating… … Wikipedia
H1 antagonist — An H1 antagonist is a histamine antagonist of the H1 receptor that serves to reduce or eliminate effects mediated by histamine, an endogenous chemical mediator released during allergic reactions. Agents where the main therapeutic effect is… … Wikipedia
